FRIDAY, Feb. 28, 2025 (HealthDay News) — GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has concluded. Earlier research had potentially linked these drugs — which are used to treat type 2 diabetes and obesity — with suicidal thoughts and self-harm,Continue Reading

WEDNESDAY, Feb. 5, 2025 (HealthDay News) — “Yo-yo” dieting — repeatedly losing and gaining weight — can significantly increase risk of kidney disease among people with type 1 diabetes, a new study warns. Diabetics with greater weight fluctuations experienced a 40% decline in their kidneys’ ability to filter toxins fromContinue Reading

FRIDAY, Jan. 24, 2025 (HealthDay News) — People can reverse their type 2 diabetes through a combination of calorie cutting and medication, a small clinical trial says. Overweight and obese adults caused their diabetes to go into remission by following a calorie-restricted diet and taking the prescription diabetes drug dapagliflozin,Continue Reading